<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Copyright &#239;&#8250;&#8482; 2002 Genetics Society America <br />  <br />  <br />  <br />           IBD2 Encodes Novel Component Bub2p-Dependent Spindle <br />                Checkpoint Budding Yeast Saccharomyces cerevisiae <br />  <br />                                                 Hyung-Seo Hwang Kiwon Song1 <br />                              Department Biochemistry, College Science, Yonsei University, Seoul 120-749, Korea <br />                                                       Manuscript received November 30, 2001 <br />                                                       Accepted publication March 25, 2002 <br />  <br />  <br />                                                               <span id='am-1' about='protege:abstract' typeof='owl:Thing'>ABSTRACT</span> <br />                 During mitosis, genomic integrity maintained proper coordination mitotic events through <br />              spindle checkpoint. The bifurcated spindle checkpoint blocks cell cycle progression metaphase by <br />              monitoring unattached kinetochores inhibits mitotic exit response incorrect orientation of <br />              mitotic spindle. Bfa1p spindle checkpoint regulator budding yeast Bub2p checkpoint <br />              pathway proper mitotic exit. We isolated novel Bfa1p interacting protein named Ibd2p the <br />              budding yeast Saccharomyces cerevisiae. We IBD2 (Inhibition Bud Division 2) essential <br />              gene deletion mutant proceeded cell cycle presence microtubule-destabilizing <br />              drugs, inducing sharp decrease viability. In addition, overexpression Mps1p caused partial <br />              mitotic arrest ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172;, suggesting IBD2 encodes novel component spindle <br />              checkpoint downstream MPS1. Overexpression Ibd2p induced mitotic arrest increased levels <br />              Clb2p wild type mad2&#226;&#338;&#172;, deletion mutants BUB2 BFA1. Pds1p stabilized <br />              overexpression Ibd2p wild-type cells. The mitotic arrest defects observed ibd2&#226;&#338;&#172; the <br />              presence nocodazole restored additional copies BUB2, BFA1, CDC5, extra <br />              copy IBD2 rescue mitotic arrest defects bub2&#226;&#338;&#172; bfa1&#226;&#338;&#172;. The mitotic arrest defects of <br />              ibd2&#226;&#338;&#172; recovered MAD2, vice versa. Analysis double mutant combinations ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;, <br />              ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;, ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172; showed IBD2 belongs BUB2 epistasis group. Taken together, these <br />              data demonstrate IBD2 encodes novel component BUB2-dependent spindle checkpoint <br />              pathway functions upstream BUB2 BFA1. <br />  <br />  <br />  <br /> C    ELLS ensure genomic integrity division <br />       checkpoints control cell cycle pro- <br /> gressions monitoring successful completion of <br />                                                                             dle checkpoint absence spindle damage <br />                                                                             wild-type cells spindle checkpoint <br />                                                                             mutants, placing MPS1 upstream spindle check- <br /> preceding processes. One mitotic checkpoint, known                          point genes (Hardwick et al. 1996). The spindle check- <br /> as spindle checkpoint, monitors assembly                        point bifurcates separate signaling pathways, <br /> orientation mitotic spindle equal segrega-                   MAD/BUB spindle assembly checkpoint meta- <br /> tion replicated chromosomes mitosis. By sens-                     phase arrest BUB2-dependent pathway block <br /> ing defects microtubule cytoskeleton, spindle                    mitotic exit cytokinesis (Alexandru et al. 1999; Li <br /> checkpoint arrests cells metaphase prevents exit                     1999). <br /> <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> mitosis regulation Cdk activity.                           Bub1p, Bub3p, Mad1p, Mad2p, Mad3p form a <br /> The spindle checkpoint vital maintaining genomic                     conserved spindle assembly checkpoint monitors <br /> stability cell division, deficiency                      attachment bipolar microtubules kineto- <br /> checkpoint lead genomic instability associated                       chores sister chromatids delays metaphase- <br /> with cancer (Cahill et al. 1998). Genetic studies                        <span id='am-4' about='protege:TO' typeof='owl:Thing'>to</span>-anaphase transition response spindle assembly <br /> budding yeast identified components                         defects inhibiting Cdc20p (Fang et al. 1998; Hwang <br /> the spindle checkpoint isolating mutants                      et al. 1998). Cdc20p key component anaphase- <br /> no longer sense spindle depolymerization died rap-                      promoting complex (APC) targets B-type cyclin <br /> idly presence microtubule-depolymerizing                          Clb5p anaphase inhibitor Pds1p degrada- <br /> drugs nocodazole benomyl (Hoyt et al. 1991;                      tion ubiquitin-mediated proteolysis trigger chro- <br /> Li Murray 1991). These components include                               mosome separation anaphase onset (Zachariae et <br /> MAD1, MAD2, MAD3, BUB1, BUB2, BUB3, MPS1.                               al. 1998; Shirayama et al. 1999). Homologs yeast <br /> Overexpression MPS1 sufficient activate spin-                  Mad1p, Mad2p, Bub1p, Bub3p identified <br />                                                                             localized unattached kinetochores higher eu- <br />                                                                             karyotes, including mammalian cells (Chen et al. 1996, <br />   1 <br />                                                                             1998; Taylor McLeon 1997; Taylor et al. 1998; <br />    Corresponding author: Department Biochemistry, College Sci- <br /> ence, Yonsei University, Seoul 120-749, Korea.                              Martinez-Exposito et al. 1999), mecha- <br /> E-mail: bc5012@yonsei.ac.kr                                                 nism senses spindle defects understood. <br /> Genetics 161: 595&#226;&#8364;&#8220;609 ( June 2002) <br />  596                                                   H.-S. Hwang K. Song <br />  <br /> Vertebrate homologs Cdc20p Pds1p                   cells treated 15 &#226;?&#174;g/ml nocodazole 0, 3, 6 hr, <br /> been identified, suggesting spindle assembly check-            respectively, plated YPD nocodazole, and <br />                                                                     percentage viability time point calculated by <br /> point mechanisms conserved eukaryotes                   dividing number colonies formed 0, 3, 6 hr by <br /> (Zou et al. 1999).                                                  number time 0 (Straight Murray 1997). For <br />    Bub2p present spindle pole body, micro-            plate assays, equivalent numbers cells grown YPD an <br /> tubule-organizing center yeast, forms separate             OD600 1.0 serially diluted, spotted YPD (&#226;&#171;&#186;) <br /> branch spindle checkpoint pathway controls              benomyl YPD (&#226;&#171;&#185;) benomyl (10 &#226;?&#174;g/ml) plates, incu- <br />                                                                     bated 25&#226;&#172;&#353; 3&#226;&#8364;&#8220;4 days. To assay cell cycle progression, cells <br /> mitotic exit timing cytokinesis (Fesquet et              extra new bud(s) counted cells arrested <br /> al. 1999; Fraschini et al. 1999; Li 1999). In fission           &#226;?&#163;-factor released presence nocodazole <br /> yeast Schizosaccharomyces pombe, Bub2p homolog                  (15 &#226;?&#174;g/ml) 3 hr. Before counting, cells time <br /> Cdc16p interacts Byr4p form two-component                 point briefly fixed 70% ethanol sonicated lightly. <br /> GTPase activating protein (GAP) stimulates                    Yeast two-hybrid screen: Yeast two-hybrid screening per- <br />                                                                     formed essentially following Gyuris et al. (1993). The full- <br /> GTPase activity Spg1p coordinate onset                 <span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> BFA1 subcloned pLex202 &#226;&#171;&#185; PL used the <br /> cytokinesis (Furge et al. 1998; Jwa Song 1998).                 bait screen. For interactor hunt, EGY48 BFA1/ <br /> BFA1, putative byr4 homolog budding yeast             pLex202 &#226;&#171;&#185; PL transformed cDNA library pJG4-5, <br /> also known IBD1 BYR4, reported                 expression cloned cDNA the <br /> to function BUB2-dependent spindle checkpoint                control GAL1-inducible promoter. A total 50,000 colo- <br />                                                                     nies screened. True positive interaction verified by <br /> for mitotic exit cytokinesis (Alexandru et al. 1999;            leucine assay EGY48, chromosomal LEU2 replaced <br /> Lee et al. 1999; Li 1999). The simplest model budding            LexAop6-LEU2. True positives grew SC-leu dropout <br /> yeast Bub2p Bfa1p form              media presence galactose/raffinose not <br /> a GAP activity inhibits Tem1p prevent cells            glucose, cDNA expressed galactose/raffinose <br /> exiting mitosis, checkpoint activated. Re-              only. To confirm interaction Ibd2p Bfa1p, <br />                                                                     full-length IBD2 open reading frame (ORF) subcloned <br /> cently Bub2p checkpoint, including Bub2p, Bfa1p,                pJG4-5 two-hybrid assay performed BFA1. <br /> and Tem1p, shown monitor spindle orienta-                  DNA manipulations strain constructions: The BFA1 <br /> tion anaphase inhibit mitotic exit               ORF amplified PCR genomic DNA 5&#226;&#172;&#732; <br /> nuclear migration bud delayed (Bardin et                oligonucleotide 5&#226;&#172;&#732;-TTGGATCCCTATGTCAATTAG-3&#226;&#172;&#732; the <br /> al. 2000; Bloecher et al. 2000; Pereira et al. 2000).               3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-CAATGGATCCGGCTAAAGGGCTAAT <br />                                                                     CTTTTG-3&#226;&#172;&#732; subcloned BamHI site pLex202 &#226;&#171;&#185; <br /> Mitotic exit ultimately repressed inhibiting Cdh1p/           PL used bait two-hybrid screening. To express <br /> Hct1p, targets degradation mitotic cyclin              hemagglutinin (HA)-tagged BFA1 CEN plasmid its <br /> Clb2p APC (Schwab et al. 1997; Visintin                 endogenous promoter, promoter ORF BFA1 <br /> et al. 1997; Zachariae et al. 1998).                                amplified 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-TGCTCTAGAC <br />    In study, discuss function IBD2,            GGAGCAAGAGATAGTCTGAG-3&#226;&#172;&#732; containing XbaI site and <br />                                                                     3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-ACAGGATCCATCTTTTGTCGAAT <br /> we isolated basis interaction BFA1 in <br />                                                                     TGATTACCATGTT-3&#226;&#172;&#732; containing BamHI site sub- <br /> budding yeast, present evidence IBD2 plays               cloned pTS903CL (a gift Dr. Toh-e, Tokyo Univer- <br /> role spindle checkpoint pathway belongs               sity). The ORF IBD2 amplified PCR genomic <br /> the BUB2 epistasis group.                                           DNA 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-GGGTTTATATGAATC <br />                                                                     ATAGACTAATATAG-3&#226;&#172;&#732; 3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-CCTG <br />                                                                     TTACTATTTAGTCATAATACCGC-3&#226;&#172;&#732; subcloned into <br />                MATERIALS AND METHODS                                SpeI SacI sites pRS316 pRS315 T-vector <br />                                                                     (Promega, Madison, WI). The ORF IBD2 sub- <br />    Yeast strains, cultures, cell cycle arrest, release: The     cloned pJG4-5 amplifying 5&#226;&#172;&#732; oligonucleotide <br /> Saccharomyces cerevisiae strains used study listed   5&#226;&#172;&#732;-CCGGAATTCAAGAAAATGACACCTACAAACC-3&#226;&#172;&#732; containing <br /> Table 1. Yeast cells grown YPD medium (1% yeast             EcoRI site 3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-TTCCTCGAGTA <br /> extract, 2% bactopeptone, 2% glucose) synthetic           ATAATGTTGACTATCTATTC-3&#226;&#172;&#732; containing XhoI site. For <br /> complete (SC) dropout media prepared yeast nitrogen            overexpression IBD2 GAL10-1 promoter, the <br /> <span id='am-161' about='xsp:base' typeof='owl:Thing'>base</span> (YNB) necessary supplements. To induce expressions         ORF IBD2 amplified 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;- <br /> from GAL10-1 GAL1 promoter, cells grown midlog            ATCGAATTCAAAATGACACCTACAAACCAATC-3&#226;&#172;&#732; containing <br /> phase 2% glucose transferred SC dropout media            EcoRI site 3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-TAAGGATCCC <br /> with raffinose 4 hr, 2% galactose added culture,    TATCTATTCCTTTTCC-3&#226;&#172;&#732; containing BamHI site sub- <br /> and cells incubated 2% raffinose/galactose         cloned pMW20. <br /> 12&#226;&#8364;&#8220;14 hr 29&#226;&#172;&#353;. Cell cycles log phase cells (5 &#226;&#171;&#187; 106 cells/        To make YSK1 strain IBD2 ORF tagged with <br /> ml) arrested final concentration 6 &#226;?&#174;m &#226;?&#163;-factor       Myc His 3&#226;&#172;&#732; end integrated chromosome <br /> (Sigma, St. Louis) 0.1 m hydroxyurea (HU; Sigma) 3           IBD2 <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-87' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span>knockout</span> strain (CDLY011), full-length ORF <br /> hr released cell cycle arrest washing cultures      IBD2 amplified 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-TATCTG <br /> in fresh medium times.                                      CAGCATAGACTAATATAGATAG-3&#226;&#172;&#732; 3&#226;&#172;&#732; oligonucleo- <br />    Assays sensitivity microtubule-destabilizing drugs: For   tide 5&#226;&#172;&#732;-ACTCTGCAGTTCATCTCTTGGTGGATTC-3&#226;&#172;&#732; sub- <br /> nocodazole treatment, cells grown midlog phase (5 &#226;&#171;&#187;         cloned PstI site pTS905IT (a gift Dr. Toh-e, <br /> 106 cells/ml) YPD 29&#226;&#172;&#353; nocodazole added           Tokyo University). IBD2-Myc-His/pTS905IT linearized <br /> final concentration 15 &#226;?&#174;g/ml 10 mg/ml stock            EcoRI, transformed CDLY012 (ibd2&#226;&#338;&#172;), selected <br /> DMSO. Cells incubated 25&#226;&#172;&#353; presence nocoda-        SC-trp plates. YSK2, YSK3 (both ibd2&#226;&#338;&#172;), YSK5 (ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;), <br /> zole, specified. To assay viability, number      YSK7 (ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;), YSK9 (ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;), YSK10 (ibd2&#226;&#338;&#172; <br />                               IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                                  597 <br />  <br />                                                                TABLE 1 <br />                                                      Yeast strains used study <br />  <br />          Strain                                          Genotype                                          Source <br />          W303               MATa ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15 <br />          FY1679C            MATa ura3-52 leu2-1 his3/MAT&#226;?&#163; ura3-52 leu2-1 his3                                F. Galibert <br />          EGY48              MATa LEU2::LexAop6-LEU2 ura3 his3 trp1 GAL&#226;&#171;&#185;                                      J. Kim <br />          CDLY011            MATa IBD2::KanMX4 ura3-52 leu2-3 112 trp1-289 his3-1                             C. Rodriquez <br />          CDLY012            MAT&#226;?&#163; IBD2::KanMX4 ura3-52 3-200 trp1-63                                      C. Rodriquez <br />          FY1674             MATa BFA1::KanMX4 ura3-52 leu2&#226;&#338;&#172;1 his3                                            F. Galibert <br />          RHC 15.1           MATa MAD2::URA3 ura3-1 leu2,3-112 his3-11 trp1-1 ade2-1 can1-100                 R-H. Chen <br />          MAY2052            MAT&#226;?&#163; BUB2::URA3 lys2-801 his3-&#226;&#338;&#172;200 leu2-3,112 ura3-52 GAL&#226;&#171;&#185;                       A. Hoyt <br />          KT1374             MATa DYN1::HIS3 leu2 ura3-52 his3                                                K. Tatchell <br />          YSK1               MAT&#226;?&#163; IBD2::KanMX4 IBD2-Myc, His TRP ura3-52 3-200 trp1-63                    This study <br />          YSK2               MATa IBD2::URA3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15                       This study <br />          YSK3               MATa IBD2::HIS3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15                       This study <br />          YSK4               MAT&#226;?&#163; IBD2::KanMX4 BUB2::URA3                                                     This study <br />          YSK5               MATa IBD2::HIS3 BUB2::URA3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15            This study <br />          YSK6               MATa IBD2::KanMX4 MAD2::URA3                                                     This study <br />          YSK7               MATa IBD2::HIS3 MAD2::URA3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15            This study <br />          YSK8               MATa BFA1::HIS3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15                       K. Song <br />          YSK9               MATa IBD2::HIS3 DYN1::URA3                                                       This study <br />          YSK10              MATa IBD2::HIS3 ura3-52 leu2&#226;&#338;&#172;1 his3 BFA1::KanMX4                                 This study <br />          YSK11              MATa BUB2::TRP1 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15                       This study <br />  <br />  <br />  <br /> bfa1&#226;&#338;&#172;) constructed PCR-based gene deletion (Wach             62.5 mm &#226;?&#164;-mercaptoethanol 90 min 30&#226;&#172;&#353;. Microtubules <br /> et al. 1994; Longtine et al. 1998) using 5&#226;&#172;&#732; 3&#226;&#172;&#732; primers      stained 1:100 diluted anti-&#226;?&#163;-tubulin mouse mono- <br /> contained 50 nucleotides spanning start stop codons           clonal antibody (Sigma) followed 1:50 diluted Texas red- <br /> of targeted genes, respectively. For YSK2, URA3             conjugated anti-mouse IgG (Molecular Probes, Eugene, OR) <br /> pRS316 amplified 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-CAA              mounted DAPI. For microscopy, cells were <br /> GAAAATGACACCTACAAACCAATCTAGTGGAACGACTAA                              observed &#226;&#171;&#187;100 objective Zeiss (Thornwood, NY) <br /> TGCATCTGTGGAGGTACGTACTGAGAGTGCACCACGC-3&#226;&#172;&#732;                             Axioskop Leica (Deerfield, IL) fluorescence DMR. <br /> and 3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-GACTATCTATTCCTTTTCC                    Photographs taken Tmax 400 film negatives <br /> TACTATCTTGTTCATCTCTTGGTGGATTCGGCATACGC                               scanned Proimager 8200 (Pixelcraft) figures, <br /> TCCTTACGCATCTGTGCGG-3&#226;&#172;&#732;. For YSK3, HIS3 pRS303                   alternatively images taken directly using Leica DC200 <br /> was amplified 5&#226;&#172;&#732;-GAAGAAAATGACACCTACAAACCAA                      Leica DC viewer. <br /> TCTAGTGGAACGACTAATGCATCTGAGCTTGGTGAGCG                                  Fluorescence-activated cell sorter analysis: For flow cytome- <br /> CTAGGAGTCAC-3&#226;&#172;&#732; 5&#226;&#172;&#732;-GACTATCTATTCCTTTTCCTAC                         try, budding yeast cells prepared essentially described <br /> TATCTTGTTCATCTCTTGGTGGATTCGGCTCGTTCAGAA                              Paulovich Hartwell (1995). Briefly, cells fixed <br /> TGACACGTATAG-3&#226;&#172;&#732;. PCR products transformed                  70% ethanol overnight 4&#226;&#172;&#353; washed 50 mm sodium <br /> W303, selected using URA3 HIS3 markers, verified             citrate (pH 7.5). A total 4 &#226;&#171;&#187; 106 cells resuspended in <br /> by genomic PCR Southern blotting. The PCR prod-             0.5 ml 50 mm sodium citrate incubated 250 &#226;?&#174;g/ <br /> uct used construct YSK3 transformed MAY2052         ml RNase A followed 1 mg/ml proteinase K 1 hr 50&#226;&#172;&#353;, <br /> (bub2&#226;&#338;&#172;), RHC 15.1 (mad2&#226;&#338;&#172;), KT1374 (dyn1&#226;&#338;&#172;), YSK8                  respectively. After adding 0.5 ml propidium iodide 50 mm <br /> (bfa1&#226;&#338;&#172;) construct YSK5 (ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;), YSK7 (ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;),           sodium citrate (final concentration 8 &#226;?&#174;g/ml), samples were <br /> YSK9 (ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;), YSK10 (ibd2&#226;&#338;&#172;bfa1&#226;&#338;&#172;), respectively.             incubated dark 12&#226;&#8364;&#8220;24 hr 4&#226;&#172;&#353; sonicated <br /> YSK4 (ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;) YSK6 (ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;) essen-             briefly just fluorescence-activated cell sorter (FACS) <br /> tially following Sena et al. (1973). Diploids constructed    analysis. For sample, 20,000 cells analyzed a <br /> by mating CDLY011 (ibd2&#226;&#338;&#172;) MAY2052 (bub2&#226;&#338;&#172;) CDLY012             Becton Dickinson (San Jose, CA) fluorescence-activated cell <br /> (ibd2&#226;&#338;&#172;) RHC 15.1 (mad2&#226;&#338;&#172;) opposite mating types             analyzer. For standard DNA content FACS <br /> the surface agar plates sporulated sporulation        analysis, &#226;?&#163;-factor-treated haploid wild-type (W303) cells [G1 <br /> plates 25&#226;&#172;&#353; 6&#226;&#8364;&#8220;7 days. Tetrads resuspended 1 ml         (1N)], wild-type cells log phase [G1 (1N) G2 (2N)], <br /> ddH2O, incubated 0.25 mg zymolase 20T (Seikagaku,               wild-type diploid (FY1679C) cells log phase (2N and <br /> Rockville, MD) overnight 30&#226;&#172;&#353; gentle shaking, sonicated       4N) used. <br /> briefly, spread YPD. The genotype spore colony           Coprecipitation immunoblot: To detect coprecipita- <br /> was determined replica plating selective media.                tion Bfa1p/Ibd1p Ibd2p, YSK1 cells transformed with <br />    Microscopic techniques: To observe nuclei cell shape,         BFA1-HA/pTS903CL grown 5 &#226;&#171;&#187; 106 cells/ml and <br /> cells fixed 70% ethanol 5 sec, washed twice         proteins extracted H-buffer [25 mm Tris-HCl pH 7.4, <br /> PBS, briefly sonicated, mounted 1 &#226;?&#174;g/ml 4&#226;&#172;&#732;,6-diami-         15 mm EGTA pH 7.5, 15 mm MgCl2, 0.1% Triton X-100, 10% <br /> dino-2-phenylindole (DAPI). For immunostaining, cells           glycerol, 1 mm NaN3, 0.6 mm sodium vanadate pH 7.0, 1&#226;&#171;&#187; <br /> fixed incubating 3.7% formaldehyde 2 hr, washed            protease cocktail DMSO (Boehringer Mannheim, Indianap- <br /> with KPO4 (pH 6.5) twice, resuspended KPO4 (pH 6.5)           olis), 1 mm dithiothreitol, 5 mg/ml phenylmethylsulfonyl <br /> containing 1.2 m sorbitol. Fixed cells permeabilized       fluoride] beadbeating (Mark et al. 1990). The cell lysate <br /> a final concentration 300 &#226;?&#174;g/ml zymolase (Seikagaku)          incubated anti-HA antibody (Novagen) 2 hr fol- <br />  598                                                H.-S. Hwang K. Song <br />  <br /> lowed Protein A-Sepharose (Sigma) 1 hr 4&#226;&#172;&#353;, and <br /> the Protein A-Sepharose washed twice H-buffer. SDS <br /> sample buffer (6&#226;&#171;&#187;) added resin, resin was <br /> boiled 5 min, proteins resolved using 10% <br /> SDS-PAGE. The resolved proteins transferred nitro- <br /> cellulose membrane incubated polyclonal rab- <br /> bit anti-HA antisera polyclonal mouse anti-Myc antisera <br /> (Upstate Laboratories), respectively. Bound antibodies were <br /> detected anti-rabbit anti-mouse IgG-HRP ( Jackson Im- <br /> munochemicals, West Grove, PA) enhanced chemilumi- <br /> nescence (ECL) reagents (Amersham, Arlington Heights, IL). <br />    For immunoblots, cell extracts prepared described <br /> and protein concentration yeast extract deter- <br /> mined dye-binding assay (Pierce, Rockford, IL ). A total <br /> of 35 &#226;?&#174;g total protein extract separated by <br /> 8% SDS-PAGE, transferred membrane, incubated <br /> with polyclonal goat anti-Clb2 antisera (Santa Cruz Biotech- <br /> nology), polyclonal rabbit anti-Pds1 antisera (Santa Cruz Bio- <br /> technology), monoclonal rabbit anti-actin antisera (Calbio- <br /> chem-Novabiochem, La Jolla, CA) followed anti-goat or <br /> anti-rabbit IgG-HRP detected ECL. <br />  <br />  <br />                          RESULTS <br />  <br />    IBD2 isolated interaction BFA1 bud- <br /> ding yeast: Loss BFA1 results reduced viability in <br /> the presence microtubule-destabilizing drugs, dem- <br /> onstrating function spindle checkpoint bud- <br /> ding yeast (Alexandru et al. 1999; Li 1999). To identify <br /> new components BFA1-dependent spindle check-                Figure 1.&#226;&#8364;&#8221; Ibd2p isolated Bfa1p-interacting pro- <br /> point, performed yeast two-hybrid screen. An open           tein yeast two-hybrid screen. (A) Ibd2p directly interacts <br /> reading frame YNL164C encodes potential Bfa1p             Bfa1p yeast two-hybrid assay. The specific positive <br />                                                                  interaction Ibd2p Bfa1p verified LEU assay <br /> interacting protein isolated, named IBD2            true positives grow galactose/raffinose <br /> (Inhibition Bud Division 2) basis overex-       SC-ura, his, leu, trp (left) glucose SC-ura, his, leu, <br /> pression phenotypes described below. Ibd2p exhibited             trp (right), expression IBD2 cDNA under <br /> specific interactions Bfa1p yeast two-hybrid         control GAL1 promoter. Lanes 1 2 positive <br /> LEU assay, IBD2 GAL1 promoter                 negative controls, respectively. Lane 3 shows specific <br />                                                                  interaction Ibd2p Bfa1p, bait screen, SC <br /> interacted BFA1 expression in-            gal/raff-ura, his, leu, trp SC glu-ura, his, leu, trp. <br /> duced galactose/raffinose (Figure 1A). To verify          (B) Ibd2p coprecipitates Bfa1p. Strain YSK1, which <br /> direct interaction Bfa1p Ibd2p, constructed            IBD2 tagged Myc His integrated chromo- <br /> strain YSK1 IBD2 tagged Myc His             ibd2&#226;&#338;&#172;, transformed low copy plasmid car- <br /> its C terminus integrated chromosome             rying BFA1-HA (pTS903CL/BFA1-HA), Myc-tagged Ibd2p <br />                                                                  HA-tagged Bfa1p coexpressed endoge- <br /> ibd2&#226;&#338;&#172; expressed endogenous pro-                nous promoters (lane 2). Wild-type cells transformed <br /> moter. YSK1 wild-type cells transformed            low copy plasmid carrying BFA1-HA (pTS903CL/BFA1- <br /> a low copy plasmid carrying BFA1-HA endoge-            HA; lane 1). Strain YSK1 transformed pTS903CL <br /> nous promoter. When HA-tagged Bfa1p purified                 vector negative control (lane 3). HA-tagged Bfa1p <br /> with anti-HA antibody, HA-tagged Bfa1p exclusively co-           purified anti-HA antibody Protein A-Sepharose. <br />                                                                  Lane 2 shows HA-tagged Bfa1p exclusively coprecipitated <br /> precipitated Myc-tagged Ibd2p expressed YSK1             Myc-tagged Ibd2p. Lane 1 shows Ibd2p wild type <br /> (Figure 1B).                                                     detected anti-Myc lane 3 shows Myc- <br />    We verified expression IBD2 S. cerevisiae        tagged Ibd2p pTS903CL vector did interact. The <br /> Northern blot (data shown). IBD2 encodes protein           purified HA-tagged Bfa1p detected by <br /> predicted contain 352 amino acids. A BLASTP search            immunoblotting anti-HA antibody Myc-tagged Ibd2p <br />                                                                  detected anti-Myc antibody, respectively. (C) The pre- <br /> of sequences GenBank using full-length Ibd2p              dicted protein structure Ibd2p containing motif of <br /> sequence revealed meaningful similarity, motif          CCPHHHYENLS amino acids 262 273 is <br /> search showed Ibd2p contains conserved se-                frequently chitinase families e-MOTIF database <br /> quence amino acids 263 273 (CCPHHHY-                 search. Boldface letters indicate amino acids conserved be- <br />                                                                  tween Ibd2p proteins motif. <br /> ENLS) chitinase families (Figure 1C) <br /> (Huang Brutlag 2001). A similar motif also <br /> been BIK1 DFG10, shown Figure 1C <br /> (Berlin et al. 1990; Mosch Fink 1997). <br />                               IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                          599 <br />  <br />                                                                    ml benomyl exhibited similar degree hypersensitiv- <br />                                                                    ity mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172; cells. For experiments <br />                                                                    described Figures 2&#226;&#8364;&#8220;5, used spindle checkpoint <br />                                                                    mutants isogenic W303 background bub2&#226;&#338;&#172;. <br />                                                                    We bub2&#226;&#338;&#172; W303 (YSK11) confirmed <br />                                                                    obvious difference physiological re- <br />                                                                    sponses bub2&#226;&#338;&#172; strains different back- <br />                                                                    grounds. <br />                                                                       Another <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span>phenotype</span> spindle checkpoint-defective <br />                                                                    mutants repeated budding mitotic arrest in <br />                                                                    presence microtubule-destabilizing drugs. To in- <br />                                                                    vestigate hypersensitivity ibd2&#226;&#338;&#172; cells to <br />                                                                    nocodazole inability arrest cell <br />                                                                    cycle mitosis, examined rebudding counting <br />                                                                    cells formed new bud mitotic spindle forma- <br />                                                                    tion inhibited nocodazole. ibd2&#226;&#338;&#172; cells arrested <br />                                                                    G1 &#226;?&#163;-factor released presence 15 <br />                                                                    &#226;?&#174;g/ml nocodazole number cells more <br />                                                                    bud compared wild-type and <br />                                                                    spindle checkpoint mutant cells. The number of <br />                                                                    cells new bud changed wild-type <br />                                                                    cells (W303), increased ibd2&#226;&#338;&#172; in <br />                                                                    mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172; cells (Figure 3A). <br />                                                                       We compared microscopy phenotypes of <br />                                                                    ibd2&#226;&#338;&#172; cells wild type hour 6 hr, <br />                                                                    cells arrested &#226;?&#163;-factor released 15 &#226;?&#174;g/ <br />    Figure 2.&#226;&#8364;&#8221;The deletion mutant IBD2 sensitive mi-       ml nocodazole. Wild-type cells progressed the <br /> crotubule-destabilizing drugs. (A) Viability IBD2 dele-     cell cycle mitosis, time arrested with <br /> tion mutant cells decreases sharply presence nocoda-     large bud condensed nucleus bud neck <br /> zole. Wild-type (W303), bfa1&#226;&#338;&#172; (YSK8), ibd2&#226;&#338;&#172; (YSK2), &#226;&#338;&#172;bub2          (Figure 3B, right). The ibd2&#226;&#338;&#172; cells enlarged <br /> (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) cells grown mid- <br /> log phase (5 &#226;&#171;&#187; 106 cells/ml), incubated 15 &#226;?&#174;g/ml nocoda- <br />                                                                    2 hr compared wild type (suggesting transient <br /> zole 0, 3, 6 hr, respectively, plated YPD   mitotic delay), produced aberrant extra bud(s) <br /> any nocodazole measure viability. The percentage viable      3 hr presence nocodazole (Figure 3B, <br /> cells (%) calculated relative number viable cells    bottom). Transient mitotic delay similar enlarged <br /> at time 0. Three independent experiments performed            phenotypes observed deletion mutants of <br /> and average plotted standard deviations. (B) <br /> ibd2&#226;&#338;&#172; cells sensitive benomyl plate assays. Actively <br />                                                                    BUB2 BFA1 treated microtubule-destabiliz- <br /> growing wild-type (W303), bfa1&#226;&#338;&#172; (YSK8), ibd2&#226;&#338;&#172; (YSK2), bub2&#226;&#338;&#172;        ing drugs (Hoyt et al. 1991; Fesquet et al. 1999; Li 1999; <br /> (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) cells serially diluted        data shown). This transient enlarged phenotype <br /> 10-fold spotted YPD plates (left) YPD plates    observed ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; bfa1&#226;&#338;&#172; mutants <br /> containing 10 &#226;?&#174;g/ml benomyl (right).                               following exposure nocodazole explained <br />                                                                    temporary mitotic arrest presence a <br />                                                                    functional MAD2 spindle assembly checkpoint pathway. <br />    IBD2 encodes component spindle checkpoint:             In nocodazole-treated ibd2&#226;&#338;&#172; cells, nucleus also <br /> The deletion IBD2 lethal showed                  failed properly divided mother <br /> growth defects, case BFA1 deletion          bud(s) (Figure 3B, bottom). These observations <br /> mutant (Duenas et al. 1999; data shown). To deter-             ibd2&#226;&#338;&#172; cells ultimately arrest cell <br /> mine Ibd2p functions spindle check-                 cycle mitosis progressed cell cycle <br /> point, tested sensitivity ibd2&#226;&#338;&#172; cells suble-        proper nuclear division cytokinesis, re- <br /> thal concentration nocodazole. After incubation            ported spindle checkpoint mutants including <br /> 15 &#226;?&#174;g/ml nocodazole, viability ibd2&#226;&#338;&#172; cells de-              mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172; (Hoyt et al. 1991; Fesquet et <br /> creased sharply mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;              al. 1999; Li 1999), microtubule-destabilizing <br /> cells (Figure 2A). As reported, mad2&#226;&#338;&#172; cells              drugs inhibited mitotic spindle formation. <br /> sensitive drug bub2&#226;&#338;&#172; cells (Fesquet et               To verify ibd2&#226;&#338;&#172; mutant progressed through <br /> al. 1999). To confirm results, sensitivity            cell cycle presence mitotic spindle defects <br /> ibd2&#226;&#338;&#172; cells benomyl examined conventional                spindle checkpoint mutants, ibd2&#226;&#338;&#172; cells ar- <br /> plating experiments. In plate assay shown Figure            rested &#226;?&#163;-factor released cell cycle arrest <br /> 2B, ibd2&#226;&#338;&#172; cells serially diluted presence 10 &#226;?&#174;g/         medium containing nocodazole 3 hr, their <br />  600   H.-S. Hwang K. Song <br />                              IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                                 601 <br />  <br /> DNA contents analyzed flow cytometry. Wild-                 netics wild type, Clb2p began degrade 100 <br /> type, ibd2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;, mad2&#226;&#338;&#172; cells contained            min, completely degraded 120 min, started <br /> either G1 (1N) G2 (2N) DNA content                    reaccumulate 140 min (Figure 3D). This observed <br /> absence nocodazole (Figure 3C, left). However,                 profile Clb2p ibd2&#226;&#338;&#172; cells consistent the <br /> larger proportion ibd2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172; cells con-             results ibd2&#226;&#338;&#172; cells exited mitosis pro- <br /> tained G2 (2N) DNA content compared wild type,                 gressed cell cycle presence noco- <br /> suggesting possible delay mitosis (Figure 3C, left).           dazole. Taken together, data demonstrate that <br /> After incubation nocodazole 3 hr, ibd2&#226;&#338;&#172;,               Ibd2p functions spindle checkpoint budding <br /> bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;, mad2&#226;&#338;&#172; cells displayed G2 (2N)               yeast. <br /> or higher DNA content, wild-type cells con-                 IBD2 functions downstream MPS1: To ex- <br /> tained G2 (2N) DNA content (Figure 3C, right).               amine function IBD2 spindle checkpoint <br /> The DNA content ibd2&#226;&#338;&#172; cells presence                   pathway, MPS1 overexpression phenotypes ibd2&#226;&#338;&#172; mu- <br /> absence nocodazole similar observed             tants analyzed compared bub2&#226;&#338;&#172; <br /> for bub2&#226;&#338;&#172; bfa1&#226;&#338;&#172;. The distribution DNA content                mad2&#226;&#338;&#172; checkpoint mutants introducing plas- <br /> of ibd2&#226;&#338;&#172; consistent new bud formation                  mid overexpressed Mps1p GAL1 pro- <br /> phenotypes described previously demonstrated               moter. Cells transformed plasmid vector only <br /> the ibd2&#226;&#338;&#172; cells proceeded cell cycle                used negative controls. As shown previously, the <br /> replicated DNA proper nuclear division                overexpression Mps1p sufficient cause <br /> and cytokinesis despite loss mitotic spindle.              mitotic delay activating MAD- BUB-depen- <br /> These characteristics reported spindle           dent spindle checkpoints absence spindle dam- <br /> checkpoint mutants including mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;                age, locating MPS1 upstream checkpoint com- <br /> (Hoyt et al. 1991; Fesquet et al. 1999; Li 1999).                   posed genes (Hardwick et al. 1996). However, <br />    When exposed microtubule-destabilizing drugs                  arguable Mps1p overexpression affects <br /> such nocodazole, wild-type yeast cells arrest mitosis         bifurcated spindle checkpoint pathways only <br /> through stabilization B-type cyclins ele-            MAD/BUB pathway BUB2-dependent <br /> vated activity cyclin B-associated Cdc28 kinase. Thus,           pathway, observed mitotic delay Mps1p <br /> the level Clb2 protein serves excellent marker             overexpression completely eliminated mad2&#226;&#338;&#172; but <br /> for mitotic arrest. To assess cell cycle progression        bub2&#226;&#338;&#172; mutants (Alexandru et al. 1999; Fesquet <br /> in ibd2&#226;&#338;&#172; cells, compared Clb2 protein levels ibd2&#226;&#338;&#172;            et al. 1999; Li 1999). As displayed Table 2, Mps1p <br /> and wild-type cells incubated nocodazole. Cells syn-           overexpression galactose-containing media 12 hr <br /> chronized G1 &#226;?&#163;-factor released fresh                resulted mitotic arrest 76% wild-type cells, while <br /> medium nocodazole collected 20 min                   19% cells negative control a <br /> for 140 min investigate level Clb2p. The per-             mitotic stage. This mitotic delay Mps1p overexpres- <br /> centage cells large bud nucleus            sion abolished mad2&#226;&#338;&#172;, compared the <br /> neck counted sample index                mad2&#226;&#338;&#172; negative control (Table 2). Overexpression of <br /> mitosis (Figure 3D, top). Wild-type cells gradually accu-           Mps1p ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; caused mitotic delay, <br /> mulated maintained Clb2p high levels                  delay ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; in <br /> presence nocodazole, cells arrested                wild type mad2&#226;&#338;&#172; (Table 2). A <br /> mitosis. ibd2&#226;&#338;&#172; cells accumulated Clb2p similar ki-             similar percentage ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; mutant cells in <br />  <br />  <br />  <br />    Figure 3.&#226;&#8364;&#8221;IBD2 encodes component spindle checkpoint. (A) ibd2&#226;&#338;&#172; cells produce new bud presence of <br /> nocodazole. Logarithmically growing wild-type (W303), bfa1&#226;&#338;&#172; (YSK8), ibd2&#226;&#338;&#172; (YSK2), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) <br /> cells arrested &#226;?&#163;-factor released presence 15 &#226;?&#174;g/ml nocodazole. The number cells one <br /> bud counted hour 3 hr fixation brief sonication. A total 500 cells counted time point <br /> and percentage cells bud calculated relative total counted cells. Three independent experiments <br /> were performed average plotted standard deviations. (B) The phenotypes ibd2&#226;&#338;&#172; cells presence of <br /> nocodazole. Wild-type ibd2&#226;&#338;&#172; cells arrested &#226;?&#163;-factor released presence 15 &#226;?&#174;g/ml nocodazole 5 hr. <br /> Cells taken hour fixed, briefly sonicated, stained DAPI. The shows wild-type cells incubated without <br /> nocodazole (left) nocodazole 5 hr (right). The shows phenotypes ibd2&#226;&#338;&#172; cells treated nocodazole <br /> at hour depicted. All panels scale. Bar, 5 &#226;?&#174;m. (C) ibd2&#226;&#338;&#172; cells progress subsequent cell cycle in <br /> the presence nocodazole. Wild-type (W303), ibd2&#226;&#338;&#172; (YSK2), bfa1&#226;&#338;&#172; (YSK8), bub2&#226;&#338;&#172; (MAY2052) cells arrested &#226;?&#163;-factor <br /> were released cell cycle arrest presence nocodazole 3 hr DNA contents measured flow <br /> cytometry. Cells shown (left) nocodazole treatment (right). (D) ibd2&#226;&#338;&#172; cells accumulate Clb2p <br /> when exposed microtubule-destabilizing drug. Wild-type (W303) ibd2&#226;&#338;&#172; (YSK2) cells arrested G1 &#226;?&#163;-factor and <br /> released presence nocodazole 25&#226;&#172;&#353;. Cells collected 20 min 140 min cells grown large <br /> bud nucleus neck counted sample, shown graph. Cell extracts sample were <br /> immunoblotted anti-Clb2 anti-actin antibody (as loading control). <br />  602                                                H.-S. Hwang K. Song <br />  <br />  <br />  <br />  <br />    Figure 4.&#226;&#8364;&#8221;The overexpression IBD2 induces mitotic arrest. (A) Cells overexpressing IBD2 arrested M phase. Wild- <br /> type (W303), bfa1&#226;&#338;&#172; (YSK8), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) cells transformed pMW20/IBD2 pMW20L/ <br /> IBD2 overexpression IBD2 GAL10-1 promoter induced 12 hr. Cells M phase counted after <br /> fixation staining DAPI. The strains transformed pMW20 used negative controls. The average <br /> of independent experiments shown standard deviation. (B) Cells overexpressing IBD2 mitotic spindle <br /> defects. The mitotic spindle visualized immunostaining antitubulin cells overexpressing IBD2. Among cells M <br /> phase Ibd2p overexpression, number cells short mitotic spindle elongated spindle counted after <br /> antitubulin staining displayed top. In section, shows cell metaphase short spindle while <br /> the displays cell elongated spindle. DNA (left) microtubule (right) staining shown. Bar, 5 &#226;?&#174;m. (C) <br /> Clb2p accumulates cells overexpressing IBD2. Cell extracts prepared (1) wild type (W303) transformed the <br /> vector pMW20 only, (2) wild type cells IBD2 overexpression induced, (3) wild-type cells incubated with <br /> nocodazole 3 hr. Extracts subjected immunoblottings using anti-Clb2p (top) anti-actin (bottom) loading <br /> control. (D) Clb2p does accumulate IBD2 overexpressed bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; mutant cells. IBD2 overexpression was <br /> induced wild-type (W303), bfa1&#226;&#338;&#172; (YSK8), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) cells, Clb2p extracts each <br /> sample analyzed immunoblotting using anti-Clb2p (top). Actin shown loading control (bottom). Lane 1, wild-type <br /> cells transformed vector control; lanes 2&#226;&#8364;&#8220;5, cells overexpressing Ibd2p [(2) wild type, (3) bfa1&#226;&#338;&#172;, (4) bub2&#226;&#338;&#172;, and <br /> (5) mad2&#226;&#338;&#172;]. (E) Pds1p stabilized wild-type cells overexpressing IBD2. Wild-type cells (W303) arrested HU re- <br /> leased presence 2% galactose induce overexpression IBD2. Cells taken 30 min 210 min, Pds1p <br /> and Clb2p examined extract immunoblots. The shows wild-type cells transformed vector pMW20 only; <br /> the shows wild-type cells overexpression IBD2 induced. Pds1p Clb2p stabilized cells <br /> overexpressing IBD2, Pds1p Clb2p wild-type cells degrade cells exit mitosis. As loading control, actin blot <br /> for sample shown. <br />                            IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                       603 <br />  <br /> mitotic delay response Mps1p overexpression im-        observed bub2&#226;&#338;&#172; cells minor mitotic arrest <br /> plies IBD2 BUB2 likely function       detected bfa1&#226;&#338;&#172;. This explained a <br /> same pathway. This incomplete mitotic delay re-           regulator Bub2p Bfa1p interacts with <br /> sponse Mps1p overexpression ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172;            Ibd2p mitotic arrest. As spindle checkpoint is <br /> also suggests IBD2 BUB2 downstream           bifurcated Mad/Bub-dependent Bub2-depen- <br /> MPS1 MPS1 functions effectively        dent pathways, mitotic arrest Ibd2p overexpres- <br /> the MAD/BUB pathway BUB2-depen-             sion mad2&#226;&#338;&#172; likely functional inde- <br /> dent pathway.                                                pendence IBD2 MAD2 different pathways and <br />    Overexpression Ibd2p induces mitotic arrest: The       supports hypothesis IBD2 functions BUB2 <br /> function Ibd2p spindle checkpoint      pathway. <br /> verified studying overexpression Ibd2p. Over-         To gain insight functional pathway <br /> expression Ibd2p GAL10-1 promoter            Ibd2p, measured level Clb2p wild- <br /> wild-type cells blocked cell cycle mitosis, re-    type mad1&#226;&#338;&#172;, bfa1&#226;&#338;&#172;, bub2&#226;&#338;&#172; cells overex- <br /> vealed DAPI staining nuclear morphology               pressing Ibd2p. As described above, overexpression <br /> counts. A total 78% wild-type cells overexpressing     IBD2 wild type resulted mitotic arrest in- <br /> Ibd2p arrested metaphase anaphase       creased Clb2p (Figure 4A Figure 4, C D). Over- <br /> with large bud, 29% wild-type cells      expression Ibd2p resulted increased level of <br /> vector control M phase (Figure 4A). These in-        Clb2p mad1&#226;&#338;&#172; bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172;, reinforcing <br /> creased mitotic arrest phenotypes Ibd2p overexpres-       conclusion Ibd2p component spindle <br /> sion strongly suggest Ibd2p functions spindle    checkpoint overexpression Ibd2p induces <br /> checkpoint.                                                  mitotic arrest BUB2 pathway upstream of <br />    To confirm overexpression Ibd2p does          BFA1 BUB2. <br /> not activate spindle checkpoint indirectly causing       We analyzed stability Pds1p wild-type cells <br /> a spindle defect, inspected microtubule structures        overexpressing Ibd2p verify mitotic arrest <br /> in cells overexpressing Ibd2p antitubulin immuno-         caused Ibd2p overexpression. For experiment, <br /> fluorescence microscopy. As seen Figure 4B,        wild-type cells synchronized S phase 0.1 m <br /> cells overexpressing Ibd2p did defect        HU released presence 2% galactose to <br /> the orientation microtubules displayed nor-       induce overexpression IBD2. In control cells ex- <br /> mal microtubule patterns M-phase cells metaphase       pressing vector alone, Pds1p accumulated gradually and <br /> or anaphase. When cells arrested mitosis Ibd2p     completely degraded 210 min release <br /> overexpression analyzed spindle        cells exit mitosis. Clb2p, degradation is <br /> patterns, 67.1% cells short spindle 32.9%       inhibited Pds1p (Cohen-Fix Koshland 1999), <br /> contained elongated spindle (Figure 4B, top). These       began decrease 90 min Pds1p started to <br /> observations demonstrated overexpression         diminish (Figure 4E). In contrast, cells the <br /> Ibd2p does generate mitotic spindle defects          overexpression Ibd2p induced, Pds1p accumu- <br /> induces mitotic arrest directly role com-   lated maintained constant high level. Clb2p <br /> ponent spindle checkpoint. The mitotic arrest         maintained stably cells (Figure 4E). <br /> caused overexpression Ibd2p wild type       The observed stability Pds1p wild-type cells overex- <br /> also validated measuring Clb2p levels. The         pressing Ibd2p confirms overexpression of <br /> of Clb2p wild-type cells overexpressing Ibd2p         Ibd2p induces mitotic arrest Ibd2p functions <br /> elevated relative actively growing wild-type cells, al-   component spindle checkpoint. <br /> though similar actin present,           IBD2 belongs BUB2 epistasis group: The above <br /> comparable wild-type cells arrested mitosis    results, including phenotypes ibd2&#226;&#338;&#172; pres- <br /> as result nocodazole treatment (Figure 4, C D).     ence nocodazole Ibd2p overexpression, <br />    To examine bifurcated spindle path-       strongly suggest IBD2 functions BUB2 branch <br /> ways pathway Ibd2p functions, Ibd2p         spindle checkpoint. The function IBD2 the <br /> overexpression phenotypes observed wild-type         BUB2 pathway validated genetic epistasis <br /> as mad2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;, bub2&#226;&#338;&#172; cells,       analysis. Blockage MAD2 BUB2 pathways in <br /> were compared negative controls strain     mad2&#226;&#338;&#172;bub2&#226;&#338;&#172; double mutant appeared ablate the <br /> overexpressed vector control. The increased         checkpoint completely, cells progressed <br /> mitotic arrest caused Ibd2p overexpression ob-        cell cycle mitotic delay and <br /> served mad2&#226;&#338;&#172; cells bfa1&#226;&#338;&#172;         rebudded rapidly single mutant (mad2&#226;&#338;&#172; <br /> at bub2&#226;&#338;&#172; (Figure 4A). When compared         bub2&#226;&#338;&#172;) presence nocodazole (Fesquet et <br /> vector control, lack mitotic arrest response    al. 1999). If IBD2 functions BUB2 branch, we <br /> Ibd2p overexpression bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; suggests        expect checkpoint blocked <br /> Ibd2p functions Bfa1p Bub2p BUB2          effectively ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; mutant in <br /> pathway. No mitotic arrest Ibd2p overexpression       ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;. We constructed ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; strain (YSK2) <br />     Figure 5.&#226;&#8364;&#8221;IBD2 belongs BUB2 epistasis group. (A) New bud formation ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; presence <br /> of nocodazole. Logarithmically growing wild-type (W303), ibd2&#226;&#338;&#172; (YSK3), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC15.1), ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; <br /> (YSK5), ibd2&#226;&#338;&#172;bfa1&#226;&#338;&#172; (YSK10), ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; (YSK7) cells incubated presence 15 &#226;?&#174;g/ml nocodazole, cells <br /> with new buds counted 20 min 160 min fixation brief sonication. A total 300 cells counted at <br /> each time point percentage cells new buds time point calculated relative total number cells <br /> counted. Three independent experiments performed average plotted standard deviations. (B) Cell cycle <br /> progression ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; presence nocodazole analysis DNA content. (a) ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; <br /> (YSK5), (b) ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; (YSK7), (c) bub2&#226;&#338;&#172; (MAY2052), (d) mad2&#226;&#338;&#172; (RHC15.1) arrested &#226;?&#163;-factor released in <br /> the presence 15 &#226;?&#174;g/ml nocodazole 110 min. Cells taken 10 min DNA contents analyzed by <br /> flow cytometry described materials methods. (C) dyn1&#226;&#338;&#172;ibd2&#226;&#338;&#172; cells proceed mitosis misoriented <br /> mitotic spindle. The dyn1&#226;&#338;&#172; ibd2&#226;&#338;&#172; double mutant constructed phenotypes compared dyn1&#226;&#338;&#172; DAPI <br /> and antitubulin immunostaining. The number cells phenotype counted shown table. In images, <br /> top, dyn1&#226;&#338;&#172; single mutant; bottom, dyn1&#226;&#338;&#172;ibd2&#226;&#338;&#172; double mutant. DAPI staining DNA (left) antitubulin staining (right) are <br /> shown. The scale panels. Bar, 5 &#226;?&#174;m. <br />                            IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                             605 <br />  <br />                                                                  double mutant especially remarkable the <br />                                                                  early stages incubation nocodazole (Figure 5A). <br />                                                                     We examined mitotic arrest defect cell <br />                                                                  cycle progression ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; by <br />                                                                  measuring DNA content. The cell cycle progression <br />                                                                  bub2&#226;&#338;&#172; mad2&#226;&#338;&#172; single mutants wild type <br />                                                                  monitored controls. In experiment, ibd2&#226;&#338;&#172;- <br />                                                                  bub2&#226;&#338;&#172;, ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, mad2&#226;&#338;&#172; cells log phase <br />                                                                  arrested &#226;?&#163;-factor released presence <br />                                                                  15 &#226;?&#174;g/ml nocodazole 110 min, DNA <br />                                                                  content analyzed 10 min flow cytometry. <br />                                                                  Approximately 80% wild-type mutant cells <br />                                                                  arrested G1 &#226;?&#163;-factor 1N DNA content. <br />                                                                  Wild-type cells gradually arrested 2N DNA <br />                                                                  content presence nocodazole cells reached <br />                                                                  mitosis (Figure 3C data shown). Similarly, both <br />                                                                  ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; double mutants pro- <br />                                                                  ceeded cell cycle displayed 2N DNA <br />                                                                  content release. However, shown Figure 5B, <br />                                                                  b, fraction ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; cells began display <br />                                                                  4N DNA content 80 min release this <br />                                                                  proportion highly increased 110 min without <br />                                                                  noticeable mitotic delay. Conversely, ibd2&#226;&#338;&#172;- <br />                                                                  bub2&#226;&#338;&#172; cells retained 2N DNA content 80 min and <br />   Figure 5.&#226;&#8364;&#8221;Continued.                                           small portion cells 4N DNA content <br />                                                                  started appear 110 min, suggesting temporal <br />                                                                  mitotic delay double mutant presence of <br /> and ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; strain (YSK3) investigated                 nocodazole (Figure 5B, a). As ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;, bub2&#226;&#338;&#172; <br /> whether increased nocodazole sensitivity detected            mad2&#226;&#338;&#172; single mutant cells showed temporal mi- <br /> by enhanced checkpoint defect double mu-              totic delay 2N DNA content 90 min and <br /> tant. First, counted rebudding double            small portion cells began 4N DNA <br /> mutants presence nocodazole, cells          content 110 min (Figure 5B, c d). Therefore, <br /> released arrest &#226;?&#163;-factor. As seen          deletion IBD2 MAD2 appeared ablate <br /> Figure 5A, proportion cells new buds           spindle checkpoint severely IBD2 <br /> in ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; double mutant similar           BUB2, suggesting IBD2 MAD2 function in <br /> the bub2&#226;&#338;&#172; single mutant, increase occurred little          separate checkpoint pathways IBD2 BUB2 <br /> more rapidly ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; comparison ibd2&#226;&#338;&#172;,             likely belong epistasis group. <br /> mad2&#226;&#338;&#172;, ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; mutants. Cell cycle progression               The BUB2 checkpoint pathway reported to <br /> as assayed new bud formation ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;                monitor anaphase spindle position. BUB2 required <br />  <br />  <br />                                                             TABLE 2 <br />                                             MPS1 overexpression ibd2&#226;&#338;&#172; cells <br />  <br />         Overexpression                       M arrest (%)                 Multibud (%)                 Normal (%) <br />         WT &#226;&#171;&#185; MPS1                             75.5   &#226;&#171;&#190;   1.5               17.0   &#226;&#171;&#190;   1.5               7.5   &#226;&#171;&#190;   1.5 <br />         WT &#226;&#171;&#185; pRS316                      19.0   &#226;&#171;&#190;   0.5                2.5   &#226;&#171;&#190;   0.5              78.5   &#226;&#171;&#190;   0.5 <br />         ibd2&#226;&#338;&#172; &#226;&#171;&#185; MPS1                            54   &#226;&#171;&#190;   0.5                 39   &#226;&#171;&#190;   0.5                 7   &#226;&#171;&#190;   0.5 <br />         ibd2&#226;&#338;&#172; &#226;&#171;&#185; pRS316                   22.5   &#226;&#171;&#190;   1.5               24.5   &#226;&#171;&#190;   1.5              52.0   &#226;&#171;&#190;   1.5 <br />         bub2&#226;&#338;&#172; &#226;&#171;&#185; MPS1                            56   &#226;&#171;&#190;   3.5                 40   &#226;&#171;&#190;   3.5                 4   &#226;&#171;&#190;   3.5 <br />         bub2&#226;&#338;&#172; &#226;&#171;&#185; pRS316                   17.5   &#226;&#171;&#190;   0.5               22.0   &#226;&#171;&#190;   0.5              60.5   &#226;&#171;&#190;   0.5 <br />         mad2&#226;&#338;&#172; &#226;&#171;&#185; MPS1                          29.5   &#226;&#171;&#190;   1.06                64   &#226;&#171;&#190;   1.06              6.5   &#226;&#171;&#190;   1.06 <br />         mad2&#226;&#338;&#172; &#226;&#171;&#185; pRS316                   25.5   &#226;&#171;&#190;   1.5               27.0   &#226;&#171;&#190;   1.5              47.5   &#226;&#171;&#190;   1.5 <br />           MPS1 overexpressed wild-type (W303), ibd2&#226;&#338;&#172; (YSK3), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC15.1) cells <br />         2% galactose 12 hr 29&#226;&#172;&#353;. Cells fixed 70% EtOH, sonicated briefly, phenotypes were <br />         examined staining DAPI. A total 300 cells counted sample; average three <br />         independent experiments presented. <br />  606                                               H.-S. Hwang K. Song <br />  <br />                           TABLE 3                                                          TABLE 4 <br />    Rescue mitotic arrest defects ibd2&#226;&#338;&#172;        Rescue mitotic arrest defects spindle checkpoint <br />                  spindle checkpoint genes                                              mutants IBD2 <br />  <br /> Rescue                     M arrest (%)       Multibud (%)       Rescue                      M arrest (%)       Multibud (%) <br /> WT                         87.2   &#226;&#171;&#190;   2.5      12.8   &#226;&#171;&#190;   2.5    bub2&#226;&#338;&#172; &#226;&#171;&#185; BFA1                   58   &#226;&#171;&#190;   2.5       42   &#226;&#171;&#190;   2.5 <br /> ibd2&#226;&#338;&#172;                      18.4   &#226;&#171;&#190;   1.5      81.6   &#226;&#171;&#190;   1.5    bub2&#226;&#338;&#172; &#226;&#171;&#185; IBD2                 46.8   &#226;&#171;&#190;   2.5     53.2   &#226;&#171;&#190;   2.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   IBD2           74.5   &#226;&#171;&#190;   1.06     25.5   &#226;&#171;&#190;   1.06   bub2&#226;&#338;&#172; &#226;&#171;&#185; BUB2                 83.7   &#226;&#171;&#190;   1.5     16.3   &#226;&#171;&#190;   1.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   BFA1           74.9   &#226;&#171;&#190;   2.5      25.1   &#226;&#171;&#190;   2.5    bub2&#226;&#338;&#172; &#226;&#171;&#185; pRS315            17   &#226;&#171;&#190;   0.5       83   &#226;&#171;&#190;   0.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   BUB2           73.2   &#226;&#171;&#190;   1.06     26.8   &#226;&#171;&#190;   1.06   bfa1&#226;&#338;&#172; &#226;&#171;&#185; BFA1                   79   &#226;&#171;&#190;   0.5       21   &#226;&#171;&#190;   0.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   MAD2           39.5   &#226;&#171;&#190;   3.5      60.5   &#226;&#171;&#190;   3.5    bfa1&#226;&#338;&#172; &#226;&#171;&#185; IBD2                   22   &#226;&#171;&#190;   1.5       78   &#226;&#171;&#190;   1.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   CDC5           72.8   &#226;&#171;&#190;   2.5      27.2   &#226;&#171;&#190;   2.5    bfa1&#226;&#338;&#172; &#226;&#171;&#185; BUB2                 73.7   &#226;&#171;&#190;   1.06    26.3   &#226;&#171;&#190;   1.06 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   pRS316    19.6   &#226;&#171;&#190;   1.5      80.4   &#226;&#171;&#190;   1.5    bfa1&#226;&#338;&#172; &#226;&#171;&#185; pRS316          19.3   &#226;&#171;&#190;   0.5     80.7   &#226;&#171;&#190;   0.5 <br />                                                                  mad2&#226;&#338;&#172; &#226;&#171;&#185; IBD2                 39.5   &#226;&#171;&#190;   1.5     60.5   &#226;&#171;&#190;   1.5 <br />   ibd2&#226;&#338;&#172; (YSK3) cells transformed pRS316/IBD2,          mad2&#226;&#338;&#172; &#226;&#171;&#185; pRS316          21.5   &#226;&#171;&#190;   2.5     78.5   &#226;&#171;&#190;   2.5 <br /> BFA1, BUB2, MAD2, CDC5 endogenous <br /> promoters, incubated presence nocodazole 3 hr,       bfa1&#226;&#338;&#172; (YSK8), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC15.1) <br /> and counted according phenotypes fixation      cells transformed pRS316/IBD2, incubated pres- <br /> 70% EtOH DAPI staining. A total 300 fixed cells      ence nocodazole 3 hr, counted according their <br /> counted sample; average independent        phenotypes fixation 70% EtOH staining with <br /> experiments presented.                                        DAPI. A total 300 fixed cells counted sample; <br />                                                                  average independent experiments presented. <br />  <br /> for prevention spindle breakdown mitotic <br /> exit yeast cells lacking dynein dynactin,         suggests IBD2 functions upstream BFA1 and <br /> both poles spindle mother cell                 BUB2 BUB2 pathway. To address where <br /> (Bloecher et al. 2000). Therefore, &#226;&#181;&#8216;25% bub2&#226;&#338;&#172;-            IBD2 functions BUB2 spindle checkpoint pathway, <br /> dyn1&#226;&#338;&#172; double mutant cells misaligned spindles               investigated loss mitotic arrest in <br /> completed anaphase initiated new bud formation,              ibd2&#226;&#338;&#172; presence microtubule-destabilizing <br /> while 95% dyn1&#226;&#338;&#172; mutant cells misaligned              drugs compensated extra copies BFA1 <br /> spindles arrested mitosis (Bloecher et al. 2000).        BUB2 CEN plasmid, summarized Table <br /> If IBD2 functions BUB2 pathway, ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;           3. We examined presence IBD2 on <br /> cells expected undergo nuclear division         CEN plasmid suppress lack mitotic arrest <br /> within mother enter cell cycle,           bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; exposure nocodazole (Table <br /> observed bub2&#226;&#338;&#172;dyn1&#226;&#338;&#172;. To confirm IBD2 func-              4). A total 82% negative controls (ibd2&#226;&#338;&#172; cells trans- <br /> tions BUB2 branch spindle checkpoint               formed CEN plasmid pRS316 only) failed to <br /> pathway, constructed ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172; double mutant               undergo mitotic arrest presence nocodazole, <br /> and compared progression mitosis ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;            75% positive controls (ibd2&#226;&#338;&#172; cells transformed <br /> with dyn1&#226;&#338;&#172;. Consistent previous reports          IBD2 CEN plasmid) able restore mitotic <br /> dyn1&#226;&#338;&#172; (Li et al. 1993; Bloecher et al. 2000), 9%            arrest. When compared ibd2&#226;&#338;&#172; mad2&#226;&#338;&#172; cells <br /> of dyn1&#226;&#338;&#172; single mutant cells contained misaligned           transformed pRS316 alone, mitotic arrest de- <br /> anaphase spindles exited mitosis formed extra             fects ibd2&#226;&#338;&#172; improved presence <br /> bud. On hand, 38% ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172; double                 MAD2 vice versa (Tables 3 4), supporting <br /> mutant cells gave rise binuclear mother cells             idea IBD2 MAD2 pathway. Extra <br /> anucleate cells contained extra bud (Fig-           copies BUB2 BFA1 able restore <br /> ure 5C). ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172; double mutant cells showed              mitotic arrest &#226;&#181;&#8216;73&#226;&#8364;&#8220;75% ibd2&#226;&#338;&#172; cells, level compa- <br /> a sharp decrease viability compared single          rable IBD2 itself (Table 3). In contrast, while <br /> mutant, possibly progression cell cycle         BFA1 BUB2 able compensate the <br /> the absence proper nuclear division, case           inability bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; cells undergo mitotic <br /> of bub2&#226;&#338;&#172;dyn1&#226;&#338;&#172; (data shown). These ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;                 arrest, extra copies IBD2 (Table 3). These <br /> phenotypes similar reported bub2&#226;&#338;&#172;-         genetic interactions IBD2 consistent data <br /> dyn1&#226;&#338;&#172; strongly suggest IBD2 belongs              described previously indicating IBD2 functions up- <br /> BUB2 epistasis group functions BUB2-depen-            stream BUB2 BFA1 BUB2-dependent spin- <br /> dent spindle checkpoint.                                         dle checkpoint pathway. Interestingly, extra copy of <br />    Mitotic arrest defects &#226;&#338;&#172;ibd2 rescued             CDC5, encodes polo-like kinase functioning in <br /> extra copies BUB2 BFA1: As described above,               mitotic exit cytokinesis, rescue deficiency <br /> the lack mitotic arrest Ibd2p overexpression            mitotic arrest ibd2&#226;&#338;&#172; (Song Lee 2001). It is <br /> bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; similar Mps1p overexpres-         hard define relationship IBD2 CDC5 <br /> sion phenotypes observed ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; mutants              solely basis result, suggests <br />                             IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                        607 <br />  <br /> a possible genetic interaction genes        observed Ibd2p overexpression caused <br /> that link checkpoint function IBD2          M-phase arrest short bipolar spindle <br /> mitotic exit.                                                 (67.1%) elongated bipolar anaphase B spindle <br />                                                               (32.9%), overexpression Bfa1p reported <br />                                                               Li (1999) induce cell cycle arrest mainly with <br />                       DISCUSSION <br />                                                               elongated anaphase B spindle. It reported pre- <br />     IBD2 new component BUB2-dependent             viously MPS1 functions upstream MAD- <br /> spindle checkpoint budding yeast: Bfa1p, Bub2p,        BUB-dependent spindle checkpoints its <br /> Tem1p associated spindle pole body (SPB)         overexpression leads cell cycle arrest predominantly <br /> of budding yeast comprise Bub2p-             short bipolar spindles (Hardwick et al. 1996). <br /> dependent spindle checkpoint (Alexandru et al. 1999;          Pds1p shown control initiation ana- <br /> Li 1999). The homologies Bfa1p Bub2p              phase mitotic exit interact mitotic exit <br /> in budding yeast Byr4p Cdc16p fission yeast        network (MEN) proteins unknown mechanisms <br /> suggest Bfa1p Bub2p form two-compo-          (Cohen-Fix Koshland 1999; Tinker-Kulberg <br /> nent GAP SPB inhibits Tem1p GTPase,           Morgan 1999). Our observation overex- <br /> thus blocking mitotic exit (Furge et al. 1998). Recent        pression Ibd2p caused M-phase arrest with <br /> reports suggest new model inhibition        short bipolar spindle elongated bipolar <br /> Tem1p Bfa1p/Bub2p GAP molecular switch           anaphase B spindle suggests possibility commu- <br /> acts Bub2p-dependent spindle checkpoint             nication Pds1p Ibd2p occur upstream <br /> prevent spindle breakdown, nuclear division, cytoki-      Bfa1p Bub2p defects spindle <br /> nesis response failure nuclear migration      formation orientation. <br /> the bud, typically results spindle orientation        The results mitotic arrest caused Ibd2p <br /> defects (Bardin et al. 2000; Bloecher et al. 2000; Per-       overexpression observed bub2&#226;&#338;&#172; bfa1/ <br /> eira et al. 2000). In model, divided nucleus    ibd1&#226;&#338;&#172;, mitotic arrest defects ibd2&#226;&#338;&#172; in <br /> and progeny SPB migrate new bud, Lte1p,              presence nocodazole restored additional <br /> guanine nucleotide exchange factor (GEF) pres-        copies BUB2 BFA1 extra copy IBD2 <br /> ent bud, activates Tem1p GTPase            rescue mitotic arrest defects bub2&#226;&#338;&#172; <br /> stimulate mitotic exit cytokinesis (Bardin et al.         bfa1&#226;&#338;&#172;, consistent model IBD2 <br /> 2000; Pereira et al. 2000). The interactions Bim1p         functions upstream BUB2 BFA1. Considering that <br /> and Kar9p cortical sites reported           Ibd2p Bfa1p directly interact extra copy <br /> properly orient mitotic spindle yeast (Korinek         BFA1 BUB2 rescues mitotic defect of <br /> et al. 2000; Lee et al. 2000; Miller et al. 2000). However,   ibd2&#226;&#338;&#172;, expect Ibd2p, Bfa1p, Bub2 <br /> it remains answered Bfa1p Bub2p       form complex transmit spindle orientation de- <br /> together sufficient act molecular switch      fect block mitotic exit. We observed Ibd2p physi- <br /> how spindle orientation defects transmitted            cally interacts Bfa1p does interact directly <br /> Bfa1p/Bub2p.                                                  Bub2p (H. Hwang, unpublished data), although <br />     We isolated novel Bfa1p interacting protein        Ibd2p Bub2p communicate Bfa1p <br /> named Ibd2p. We presented evidence IBD2             forming complex together. The observation that <br /> functions component spindle checkpoint         Ibd2p localized dot near nuclear periphery <br /> the BUB2-dependent branch pathway upstream            expressed green fluorescent protein (GFP) <br /> of Bfa1p Bub2p. IBD2 deletion mutants proceeded           fusion multicopy plasmid suggests endogenous <br /> through cell cycle presence microtubule-        Ibd2p, like Bfa1p, localized spindle pole body <br /> destabilizing drugs, causing sharp decrease      supports possibility form complex in <br /> viability. IBD2 overexpression induced mitotic arrest      spindle pole body (H. Hwang, unpublished data). <br /> wild-type cells, verified increased levels Clb2p        We observed mitotic arrest defect of <br /> and stabilization Pds1p, <span id='am-162' about='xsp:pattern' typeof='owl:Thing'>pattern</span> micro-     ibd2&#226;&#338;&#172; presence nocodazole restored by <br /> tubule structures normal cells. This mitotic     additional copies CDC5. CDC5 encodes polo-like <br /> arrest response IBD2 overexpression ob-         kinase S. cerevisiae functions component of <br /> served BUB2 slightly detected BFA1 dele-        MEN, CDC5 participates mitotic exit <br /> tion mutant cells. These results strongly suggest        pathway known (Kitada et al. 1993; Jaspersen et <br /> IBD2 functions component spindle check-           al. 1998). Cdc5p plays role regulating cytokine- <br /> point pathway upstream BUB2 BFA1. The minor            sis proposed coordinate mitotic exit cytoki- <br /> difference Ibd2p overexpression phenotypes BUB2         nesis (Song Lee 2001). A recent report showed <br /> and BFA1 deletion mutants explained regu-       phosphorylation Bfa1 Cdc5p regulates <br /> lator Bub2p Bfa1p interacts Ibd2p          checkpoint function Bfa1p (Hu et al. 2001). Our <br /> for mitotic arrest. Further study proteins interacting     data showing mitotic arrest defect ibd2&#226;&#338;&#172; is <br /> with Ibd2p answer possibility. Interestingly,      rescued additional copies CDC5 suggest IBD2 <br />  608                                                       H.-S. Hwang K. Song <br />  <br /> is likely function upstream CDC5 mitotic                    University English editing. This work supported grant <br />                                                                          Korean Ministry Science Technology (Critical Tech- <br /> exit pathway regulate function Bfa1p. However, <br />                                                                          nology 21 &#226;&#8364;&#339;Life Phenomena Function Research&#226;&#8364;?; 00-J-LF-01- <br /> the genetic interaction IBD2 CDC5                      B-60) donated K. Song partly grant Korean <br /> to confined control mitotic exit,                 Science &amp; Engineering Foundation (KOSEF 1999-2-207-003-3). <br /> deletion overexpression IBD2 does affect cyto- <br /> kinesis. <br />    Possible functions IBD2 BUB2-dependent <br />                                                                                               LITERATURE CITED <br /> pathway: Ibd2p component Bub2- <br /> dependent spindle checkpoint identified acts                  Alexandru, G., W. Zacharie, A. Schleiffer K. Nasmyth, 1999 <br />                                                                              Sister chromatid separation chromosome re-duplication are <br /> directly upstream Bfa1p Bub2p. Since Bub2p-                       regulated different mechanisms response spindle dam- <br /> dependent spindle checkpoint prevents mitotic exit                       age. EMBO J. 18: 2707&#226;&#8364;&#8220;2721. <br /> cytokinesis response spindle orientation defects,                  Bardin, A., J. R. Vistin A. Amon, 2000 A mechanism cou- <br />                                                                              pling exit mitosis partitioning nucleus. Cell 102: <br /> Ibd2p likely function transmitting signals                    21&#226;&#8364;&#8220;31. <br /> spindle integrity Bfa1p Bub2p regulating                      Berlin, V., C. A. Styles G. Fink, 1990 Bik1, protein required <br /> the exit mitosis. Ibd2p novel protein                      microtubule function mating mitosis Saccharo- <br />                                                                              myces cerevisiae, colocalizes tubulin. J. Cell Biol. 111: 2573&#226;&#8364;&#8220; <br /> homology proteins known function, contains                      2586. <br /> a conserved sequence (CCPHHHYENLS) chi-                         Bloecher, A., G. M. Venturi K. Tatchell, 2000 Anaphase <br /> tinase families (Huang Brutlag 2001). This motif                         spindle position monitored BUB2 checkpoint. Nat. Cell <br />                                                                              Biol. 2: 556&#226;&#8364;&#8220;558. <br /> is Bik1p, required proper                     Cahill, D. P., C. Lengauer, J. Yu, G. J. Riggins, J. K. Willson et al., <br /> microtubule function mitosis shows                          1998 Mutations mitotic checkpoint genes human cancers. <br /> both genetic direct physical interactions Bim1p                     Nature 392: 300&#226;&#8364;&#8220;303. <br />                                                                          Chen, R. H., J. C. Waters, E. D. Salmon A. W. Murray, 1996 <br /> and &#226;?&#163;-tubulin budding yeast (Berlin et al. 1990;                          Association spindle assembly checkpoint component XMAD2 <br /> Schwartz et al. 1997). The conservation se-                          unattached kinetochores. Science 274: 242&#226;&#8364;&#8220;246. <br /> quence Ibd2p points possible functions                    Chen, R. H., A. Shevchenko, M. Mann A. W. Murray, 1998 <br />                                                                              Spindle checkpoint protein xmad1 recruits xmad2 unattached <br /> of Ibd2p monitoring spindle orientation defects dur-                      kinetochores. J. Cell Biol. 143: 283&#226;&#8364;&#8220;295. <br /> ing mitosis. Our unpublished data suggest do-                   Cohen-Fix, O., D. Koshland, 1999 Pds1p budding yeast has <br /> main Ibd2p containing motif important                         dual roles: inhibition anaphase initiation regulation of <br />                                                                              mitotic exit. Genes Dev. 13: 1950&#226;&#8364;&#8220;1959. <br /> eliciting mitotic arrest observed overexpres-                   Duenas, E., J. L. Revuelta, F. Del Rey C. R. Vazquez De Aldana, <br /> sion Ibd2p. Further analysis genetic physical                      1999 Disruption basic phenotype analysis novel genes <br /> interactions Ibd2p proteins involved                          left arm chromosome XIV Saccharomyces cerevisiae. <br />                                                                              Yeast 15: 63&#226;&#8364;&#8220;72. <br /> proper spindle orientation Bim1p, Kar9p, Bik1p,                  Fang, G., H. Yu M. W. Kirschner, 1998 The checkpoint protein <br /> and Nud1p underway clues                            MAD2 mitotic regulator CDC20 form ternary complex <br /> the precise mechanism Ibd2p functions                        anaphase-promoting complex control anaphase transi- <br />                                                                              tion. Genes Dev. 12: 1871&#226;&#8364;&#8220;1883. <br /> spindle checkpoint.                                                      Fesquet, D., P. J. Fitzpatrick, A. L. Johnson, K. M. Kramer, J. H. <br />    Since overexpression Ibd2p induced mitotic                         Toyn et al., 1999 A Bub2p-dependent spindle checkpoint path- <br /> arrest upstream Bfa1p Bub2p, Ibd2p act                          way regulates Dbf2 kinase budding yeast. EMBO J. 18: <br />                                                                              2424&#226;&#8364;&#8220;2434. <br /> as negative regulator Tem1 GTPase, possibly                      Fraschini, R., E. Formenti, G. Lucchini S. Piatti, 1999 Bud- <br /> activating Bfa1 Bub2 GAP inhibiting GEF                        ding yeast Bub2 localized spindle pole bodies activates <br /> Lte1. We observed Ibd2p does physically inter-                      mitotic checkpoint different pathway Mad2. J. Cell <br />                                                                              Biol. 145: 979&#226;&#8364;&#8220;991. <br /> act Lte1p localized dot near nuclear                Furge, K. A., K. Wong, J. Amstrong, M. Balasubramanian and <br /> periphery expressed GFP fusion, suggesting                         C. F. Albright, 1998 Byr4 Cdc16 form two-component <br /> that localizes spindle pole body, does Bfa1p                    GTPase-activating protein Spg1 GTPase controls sep- <br />                                                                              tation fission yeast. Curr. Biol. 8: 947&#226;&#8364;&#8220;954. <br /> (H. Hwang, unpublished data). These observations                         Gyuris, J., E. Golemis, H. Chertkov R. Brent, 1993 Cdi1, a <br /> strongly suggest Ibd2p functions negatively                          human G1 S phase protein phosphatase associates with <br /> Tem1 GTPase direct interaction Bfa1p. Al-                            Cdk2. Cell 75: 791&#226;&#8364;&#8220;803. <br />                                                                          Hardwick, K. G., E. Weiss, F. C. Luca, M. Winey A. W. Murray, <br /> though direct interaction Ibd2p                          1996 Activation budding yeast spindle assembly check- <br /> and Lte1p, genome-wide two-hybrid analysis reported                        point mitotic spindle disruption. Science 273: 953&#226;&#8364;&#8220;956. <br /> that Ibd2p connected Lte1p YNL091W                         Hoyt, M. A., L. Totis B. T. Roberts, 1991 S. cerevisiae genes <br />                                                                              required cell cycle arrest response loss microtubule <br /> and Msl1p (Uetz et al. 2000). Therefore, possibility                     function. Cell 66: 507&#226;&#8364;&#8220;517. <br /> that Ibd2p acts negatively influence Lte1p                  Hu, F., Y. Wang, D. Liu, Y. Li, J. Qin et al., 2001 Regulation the <br /> excluded. Conceivably, Ibd2p function indirectly                       Bub2/Bfa1 GAP complex Cdc5 cell cycle checkpoint. Cell <br />                                                                              107: 655&#226;&#8364;&#8220;665. <br /> to inactivate Tem1p GTPase activating Bfa1p                      Huang, J. Y., D. L. Brutlag, 2001 The eMOTIF database. <br /> and inactivating Lte1p block mitotic exit                         Nucleic Acids Res. 29: 202&#226;&#8364;&#8220;204. <br /> there defects spindle formation orientation.                  Hwang, L. H., L. Lau, D. Smith, C. A. Mistrot K. G. Hardwick, <br />                                                                              1998 Budding yeast Cdc20: target spindle checkpoint. <br />   We thank Drs. J. Kim, K. Choi, M. Winey, C. Rodriquez, F. Galibert,        Science 279: 1041&#226;&#8364;&#8220;1044. <br /> A. Hoyt, A. Toh-e, M. Lonetine, F. Rey providing yeast strains   Jaspersen, S. L., J. F. Charles, R. L. Tinker-Kulberg D. O. <br /> and plasmids. We indebted Dr. Kris Gunsalus New York          Morgan, 1998 A late mitotic regulatory network controlling <br />                                  IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                                         609 <br />      cyclin destruction Saccharomyces cerevisiae. Mol. Biol. Cell 9:   Pereira, G., T. Hofken, J. Grindlay, C. Manson E. Schiebel, <br />      2803&#226;&#8364;&#8220;2817.                                                               2000 The Bub2p spindle checkpoint links nuclear migration <br /> Jwa, M., K. Song, 1998 Byr4, dosage-dependent regulator              mitotic exit. Mol. Cell 6: 1&#226;&#8364;&#8220;10. <br />      cytokinesis S. pombe, interacts possible small GTPase      Schwab, M., A. S. Lutum W. Seufert, 1997 Yeast Hct1 a <br />      pathway including Spg1 Cdc16. Mol. Cell 8: 240&#226;&#8364;&#8220;245.                  regulator Clb2 cyclin proteolysis. Cell 90: 683&#226;&#8364;&#8220;693. <br /> Kitada, K., A. L. Johnson, L. H. Johnston A. Sugino, 1993             Schwartz, K., K. Richards D. Botstein, 1997 BIM1 encodes <br />      A multicopy suppressor gene Saccharomyces cerevisiae G1           microtubule-binding protein yeast. Mol. Biol. Cell 8: 2677&#226;&#8364;&#8220; <br />      cell cycle mutant gene dbf4 encodes protein kinase              2691. <br />      identified CDC5. Mol. Cell. Biol. 13: 4445&#226;&#8364;&#8220;4457.                  Sena, P., D. N. Radin S. Fogel, 1973 Synchronous mating in <br /> Korinek, W. S., M. J. Copeland, A. Chaudhuri J. Chant, 2000               yeast. Proc. Natl. Acad. Sci. USA 70: 1373&#226;&#8364;&#8220;1377. <br />      Molecular linkage underlying microtubule orientation          Shirayama, M., A. Toth, M. Galova K. Nasmyth, 1999 APC <br />      cortical sites yeast. Science 287: 2257&#226;&#8364;&#8220;2259.                         (Cdc20) promotes exit mitosis destroying anaphase <br /> Lee, J., H.-S. Hwang, J. Kim K. Song, 1999 Ibd1p, possible              inhibitor Pds1 cyclin Clb5. Nature 402: 203&#226;&#8364;&#8220;207. <br />      spindle pole body associated protein, regulates nuclear division     Straight, A. F., A. W. Murray, 1997 The spindle assembly <br />      bud sepa <br /> </body></html>